# Purdue Pharma L.P. – FDA Inspection, Apr 15, 2011

Source: https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/ac84ae77-53b0-496a-b79a-7bfed16742d0
Source feed: FDA_Inspections

> FDA inspection 719822 of Purdue Pharma L.P., April 15, 2011. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 719822
- Company Name: Purdue Pharma L.P.
- Inspection Date: 2011-04-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1219674 - 2023-10-05](https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/817234d2-cd59-4948-a2ce-9a2fd906ed9e)
- [FDA Inspection 1084657 - 2019-03-29](https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/5c8a08a9-c10a-4fc6-875d-a0744f103817)
- [FDA Inspection 994812 - 2016-12-06](https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/cdb4e580-db3e-4dc1-8537-5416abe48590)
- FDA Inspection 979977 - 2016-07-28
- FDA Inspection 979095 - 2016-07-06

Company: https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c